Insights

Gathering insights about Excision BioTherapeutics…

Similar companies to Excision BioTherapeutics

Excision BioTherapeutics Tech Stack

Excision BioTherapeutics uses 8 technology products and services including Google Analytics, Fastly, HTTP/3, and more. Explore Excision BioTherapeutics's tech stack below.

Google Analytics
Analytics
Fastly
Content Delivery Network
HTTP/3
Miscellaneous
Webpack
Miscellaneous
Open Graph
Miscellaneous
Python
Programming Languages
reCAPTCHA
Security
Bootstrap
UI Frameworks

Media & News

Excision BioTherapeutics's Email Address Formats

Excision BioTherapeutics uses at least 2 format(s):

Excision BioTherapeutics Email Formats	Example	Percentage
FLast@excisionbio.com	JDoe@excisionbio.com	89%
Last@excisionbio.com	Doe@excisionbio.com	8%
First.Last@excisionbio.com	John.Doe@excisionbio.com	2%
FMLast@excisionbio.com	JMDoe@excisionbio.com	1%
F.Last@excision.bio	J.Doe@excision.bio	50%
First_Last@excision.bio	John_Doe@excision.bio	25%
LastF@excision.bio	DoeJ@excision.bio	25%

Frequently Asked Questions

Where is Excision BioTherapeutics's headquarters located?

Excision BioTherapeutics's main headquarters is located at San Francisco , CA US. The company has employees across 4 continents, including North AmericaEuropeAsia.

What is Excision BioTherapeutics's official website and social media links?

Excision BioTherapeutics's official website is excision.bio and has social profiles on LinkedIn.

How much revenue does Excision BioTherapeutics generate?

As of September 2024, Excision BioTherapeutics's annual revenue reached $3.8M.

What is Excision BioTherapeutics's SIC code NAICS code?

Excision BioTherapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Excision BioTherapeutics have currently?

As of September 2024, Excision BioTherapeutics has approximately 42 employees across 4 continents, including North AmericaEuropeAsia. Key team members include Chief Technology Officer: F. G.Chief Operating Officer: T. M.Chief Medical Officer: L. D.. Explore Excision BioTherapeutics's employee directory with LeadIQ.

What industry does Excision BioTherapeutics belong to?

Excision BioTherapeutics operates in the Biotechnology Research industry.

What technology does Excision BioTherapeutics use?

Excision BioTherapeutics's tech stack includes Google AnalyticsFastlyHTTP/3WebpackOpen GraphPythonreCAPTCHABootstrap.

What is Excision BioTherapeutics's email format?

Excision BioTherapeutics's email format typically follows the pattern of . Find more Excision BioTherapeutics email formats with LeadIQ.

When was Excision BioTherapeutics founded?

Excision BioTherapeutics was founded in 2015.

Excision BioTherapeutics

Biotechnology ResearchCalifornia, United States11-50 Employees

Excision BioTherapeutics is a private company focused on developing advanced gene editing therapeutics to address the medical need for the treatment of life-threatening disease caused by viral infections. Our mission is to advance gene editing therapeutics for our indications into safe and efficacious medicines that will greatly improve the lives of infected individuals around the world.

Company Overview

Headquarters: San Francisco , CA US
Website: excision.bio
SIC Code: 8733 - Noncommercial Research Organizations
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2015
Employees: 11-50

Media & News

Funding & Financials

$10M
Excision BioTherapeutics's revenue is in the range of $10M

Funding & Financials

$10M
Excision BioTherapeutics's revenue is in the range of $10M

Company Leadership

F. G.
Chief Technology Officer
✕
Access Insights for Excision BioTherapeutics and Millions of Other Companies
Sign up for full access to Excision BioTherapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Excision BioTherapeutics and Millions of Other Companies
Sign up for full access to Excision BioTherapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
T. M.
Chief Operating Officer
✕
Access Insights for Excision BioTherapeutics and Millions of Other Companies
Sign up for full access to Excision BioTherapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Excision BioTherapeutics and Millions of Other Companies
Sign up for full access to Excision BioTherapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
L. D.
Chief Medical Officer
✕
Access Insights for Excision BioTherapeutics and Millions of Other Companies
Sign up for full access to Excision BioTherapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Excision BioTherapeutics and Millions of Other Companies
Sign up for full access to Excision BioTherapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
N. K.
Vice President Operations
✕
Access Insights for Excision BioTherapeutics and Millions of Other Companies
Sign up for full access to Excision BioTherapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Excision BioTherapeutics and Millions of Other Companies
Sign up for full access to Excision BioTherapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
R. A. B.
Vice President Clinical Operations
✕
Access Insights for Excision BioTherapeutics and Millions of Other Companies
Sign up for full access to Excision BioTherapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Excision BioTherapeutics and Millions of Other Companies
Sign up for full access to Excision BioTherapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

E. X.
Vice President, Head Of Bioinformatics
✕
Access Insights for Excision BioTherapeutics and Millions of Other Companies
Sign up for full access to Excision BioTherapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Excision BioTherapeutics and Millions of Other Companies
Sign up for full access to Excision BioTherapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. G.
Senior Vice President, R&d
✕
Access Insights for Excision BioTherapeutics and Millions of Other Companies
Sign up for full access to Excision BioTherapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Excision BioTherapeutics and Millions of Other Companies
Sign up for full access to Excision BioTherapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
N. K.
Vice President Operations
✕
Access Insights for Excision BioTherapeutics and Millions of Other Companies
Sign up for full access to Excision BioTherapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Excision BioTherapeutics and Millions of Other Companies
Sign up for full access to Excision BioTherapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
R. A. B.
Vice President Clinical Operations
✕
Access Insights for Excision BioTherapeutics and Millions of Other Companies
Sign up for full access to Excision BioTherapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Excision BioTherapeutics and Millions of Other Companies
Sign up for full access to Excision BioTherapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
P. A.
Senior Director, Cmc Manufacturing, Crispr-Based Gene Therapy
✕
Access Insights for Excision BioTherapeutics and Millions of Other Companies
Sign up for full access to Excision BioTherapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Excision BioTherapeutics and Millions of Other Companies
Sign up for full access to Excision BioTherapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Excision BioTherapeutics

Metagenomi

Caribou Biosciences

Affinia Therapeutics

Dyno Therapeutics

Cadence Biomedical

Excision BioTherapeutics Tech Stack

Media & News

Excision BioTherapeutics Inc. recognized as one of the 2024's "Fierce 15 on Aug 5th '24.

Excision BioTherapeutics Inc. launched CRISPR study for HIV patients on Jan 27th '22.

Excision BioTherapeutics Inc. is developing HIV treatment known as EBT-101.

Excision BioTherapeutics Inc. hired Sara Turken on Oct 12th '21.

Excision BioTherapeutics Inc. partners with Temple University.

Excision BioTherapeutics Inc. hired Lisa Danzig as Chief Medical Officer on Jul 29th '21.

Excision BioTherapeutics Inc. hired Sumathi Sivapalasingam as Head of Translational Medicine on May 27th '21.

Excision BioTherapeutics's Email Address Formats

Frequently Asked Questions

Where is Excision BioTherapeutics's headquarters located?

What is Excision BioTherapeutics's official website and social media links?

How much revenue does Excision BioTherapeutics generate?

What is Excision BioTherapeutics's SIC code NAICS code?

How many employees does Excision BioTherapeutics have currently?

What industry does Excision BioTherapeutics belong to?

What technology does Excision BioTherapeutics use?

What is Excision BioTherapeutics's email format?

When was Excision BioTherapeutics founded?

Excision BioTherapeutics

Company Overview

Media & News

Excision BioTherapeutics Inc. recognized as one of the 2024's "Fierce 15 on Aug 5th '24.

Excision BioTherapeutics Inc. launched CRISPR study for HIV patients on Jan 27th '22.

Excision BioTherapeutics Inc. is developing HIV treatment known as EBT-101.

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?